Expression of AID in malignant melanoma with BRAFV600E mutation

13Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

BRAF-activating somatic mutations often exist in malignant melanoma. The underlying molecular mechanism of somatic BRAF mutation inductions remained to be clear. Activation-induced cytidine deaminase (AID), a member of a cytidine deaminase family, and APOBEC3B induce somatic mutations and recently have been indicated to be involved in the pathomechanism of several kinds of cancers. The aim of this study was to explore the expression level of AID and APOBEC3B in BRAF-mutation- containing malignant melanoma. Immunohistochemical study demonstrated that 9 of 10 malignant melanomas with high AID expression had BRAFV600E mutation. Eight of them developed multiorgan metastases or multiple lymph node metastases afterwards. Although the size of the patient panel was small, the results indicate that there might be an association between AID expression and BRAF mutation in melanoma. © 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Cite

CITATION STYLE

APA

Okura, R., Yoshioka, H., Yoshioka, M., Hiromasa, K., Nishio, D., & Nakamura, M. (2014). Expression of AID in malignant melanoma with BRAFV600E mutation. Experimental Dermatology. Blackwell Publishing Ltd. https://doi.org/10.1111/exd.12402

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free